Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
dermal filler
|
| gptkbp:activeIngredient |
hyaluronic acid
|
| gptkbp:approvalYear |
2003
|
| gptkbp:approvedBy |
gptkb:Sweden
|
| gptkbp:category |
aesthetic medicine
cosmetic injectable |
| gptkbp:contains |
non-animal stabilized hyaluronic acid (NASHA)
|
| gptkbp:contraindication |
active skin infection
allergy to hyaluronic acid |
| gptkbp:contrastsWith |
gptkb:Juvederm
gptkb:Belotero |
| gptkbp:countryOfOrigin |
gptkb:Sweden
|
| gptkbp:effect |
6 to 12 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Restylane
|
| gptkbp:manufacturer |
gptkb:Galderma
|
| gptkbp:marketedAs |
gptkb:Galderma
|
| gptkbp:medicalUse |
facial contouring
lip augmentation facial wrinkle reduction |
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:sideEffect |
pain at injection site
redness swelling bruising |
| gptkbp:usedBy |
dermatologists
plastic surgeons |
| gptkbp:website |
https://www.restylaneusa.com/
|
| gptkbp:bfsParent |
gptkb:Medicis_Pharmaceutical
gptkb:Nestlé_Skin_Health gptkb:Galderma |
| gptkbp:bfsLayer |
7
|